US$ 25.59
dual glp-1/gip receptor agonists Tirzepatide's Unique Mechanism of Action Targeting GLP-1, GIP & GCG
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Hernndez-Cascales J

Counsel patients regarding the risk of medullary thyroid carcinoma and the symptoms of thyroid tumors

Christine Marin, where we go through thyroid health in detail and she talks a lot about GLP ones and thyroid, um, themself

Finally, in cases where volume contraction is not the obvious mechanism of acute kidney injury, the possibility of acute interstitial nephritis should be considered

This is the result that will likely attract the most attention, because it points toward a possible therapeutic overlap between metabolic intervention and cancer outcomes
Bibcode:1993BBRC..196..141G
